Pradhan S, Kumar S, Singh D, Sood R C, Sehgal R
Antisera Division, Central Research Institute, Kasauli (H.P), Himachal Pradesh, India.
Biologicals. 2007 Jun;35(3):155-60. doi: 10.1016/j.biologicals.2006.08.001. Epub 2006 Nov 7.
Antibodies against snake venom or antivenom potency are assayed quantitatively by in-vivo neutralization test in mice, which requires large number of laboratory animals. In potency assays of biological substances such as antivenoms, it is highly desirable to avoid suffering and death of animals by substituting in-vivo method with in-vitro methods, provided such methods measure life-saving capability with precision similar to that of in-vivo method. The in-vitro tests determine the neutralizing power of antivenom by permitting the evaluation of a particular biological activity of the venom and its neutralization after mixing the venom with the antivenom [Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venom. Bull WHO 1983;61:949-956; Gutierrez JM, Rojas G, Lomonte B, Gene JA, Chaves F, Alvarado J, et al. Standardizing of assays for testing the neutralizing ability of antivenoms. Toxicon 1990;28:1127-1129; Theakston R.D.G. Comments on letter of Gutierrez et al. on standardization of assays for testing the neutralizing ability of antivenoms. Toxicon 1990;28:1131-1132; Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. Screening of snake venom for neurotoxic and myotoxic effects using simple in-vitro preparation from rodents and chicks. Toxicon 1994;32:257-265; World Health Organization Progress in characterization of venom and standardization of anti-venoms. Geneva: WHO offset publication; 1981. p. 58.]. Hence, the ideal requirements for an assay in detecting venom and venom antibody include high level of sensitivity, specificity (ability to differentiate between venom and venom antibody produced by closely related species of snakes), reproducibility and simplicity. A new in-vitro procedure for quantitative analysis of potency of ASVS by passive haemagglutination (PHA) and haemagglutination inhibition (HAI) has been explored. The methods described are simple, rapid, economical, reproducible and useful in replacing the more expensive in-vivo neutralization assays. Moreover, it also eliminates the use of laboratory animals.
抗蛇毒抗体或抗蛇毒血清效力通过小鼠体内中和试验进行定量测定,这需要大量实验动物。在抗蛇毒血清等生物物质的效力测定中,非常希望用体外方法替代体内方法,以避免动物遭受痛苦和死亡,前提是这些方法能够精确测量与体内方法相当的挽救生命能力。体外试验通过在毒液与抗蛇毒血清混合后评估毒液的特定生物活性及其中和作用来确定抗蛇毒血清的中和能力[Theakston RDG, Reid HA. 开发用于鉴定蛇毒的简单标准测定程序。《世界卫生组织公报》1983年;61:949 - 956;Gutierrez JM, Rojas G, Lomonte B, Gene JA, Chaves F, Alvarado J等人。抗蛇毒血清中和能力检测试验的标准化。《毒理学》1990年;28:1127 - 1129;Theakston R.D.G. 对Gutierrez等人关于抗蛇毒血清中和能力检测试验标准化信件的评论。《毒理学》1990年;28:1131 - 1132;Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. 使用来自啮齿动物和雏鸡的简单体外制剂筛选蛇毒的神经毒性和肌毒性作用。《毒理学》1994年;32:257 - 265;世界卫生组织 毒液鉴定和抗蛇毒血清标准化进展。日内瓦:世界卫生组织胶版印刷出版物;1981年。第58页。]。因此,检测毒液和毒液抗体的试验的理想要求包括高灵敏度、特异性(区分密切相关蛇种产生的毒液和毒液抗体的能力)、可重复性和简单性。一种通过被动血凝(PHA)和血凝抑制(HAI)对抗蛇毒血清蝮蛇毒因子(ASVS)效力进行定量分析的新体外程序已被探索。所描述的方法简单、快速、经济、可重复,并且可用于替代更昂贵的体内中和试验。此外,它还避免了使用实验动物。